
October 2, 2025
Review
New
Concept of New Approach Methodologies (NAMs) use in quasi-drug applications (Early Consideration) and Points to Consider for Clinical Evaluation of Drug-Drug Interactions using Endogenous Biomarker (Early consideration) posted
October 1, 2025
Int
New
New PMDA-ATC E-learning content has been released on the Pmda Channel
September 30, 2025
Review
New
List of Approved CDx(Companion Diagnostics): Updated Sep 19, 2025
September 30, 2025
Int
PMDA Washington D.C. Office Map Refreshed
September 30, 2025
Other
New
Recent Publications by PMDA Staff updated
September 29, 2025
Review
New
English Translation of Review Report: Datroway
September 26, 2025
Events
New
PMDA-ATC Pharmaceuticals Review Webinar 2025 applications open
September 26, 2025
Events
New
PMDA-ATC MRCT/GCP Inspection Seminar 2026 applications open
September 19, 2025
Safety
PMDA Risk Communications: Lubiprostone, etc. posted
September 18, 2025
Safety
PMDA Alert for Proper Use of Drugs: No. 7 Compliance with Measurement of Blood Lithium Levels during Treatment with Lithium Carbonate (revision) posted
October 2, 2025
New
Concept of New Approach Methodologies (NAMs) use in quasi-drug applications (Early Consideration) and Points to Consider for Clinical Evaluation of Drug-Drug Interactions using Endogenous Biomarker (Early consideration) posted
September 30, 2025
Drug
IVD
New
List of Approved CDx(Companion Diagnostics): Updated Sep 19, 2025
September 29, 2025
Drug
New
English Translation of Review Report: Datroway
Currently, there is no applicable information.